Renal safety of zoledronic acid with thalidomide in patients with myeloma: a pharmacokinetic and safety sub-study

Andrew Spencer; Andrew Roberts; Nola Kennedy; Christina Ravera; Serge Cremers; Sanela Bilic; Teresa Neeman; Michael Copeman; Horst Schran; Kevin Lynch

doi:1472-6904/8/2

Renal safety of zoledronic acid with thalidomide in patients with myeloma: a pharmacokinetic and safety sub-study

Andrew Spencer, Andrew Roberts, Nola Kennedy, Christina Ravera, Serge Cremers, Sanela Bilic, Teresa Neeman, Michael Copeman, Horst Schran, Kevin Lynch

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1-4
Journal	Pharmacology and Toxicology
Volume	8
Issue number	2
DOIs	https://doi.org/1472-6904/8/2
Publication status	Published - 2007

Access to Document

1472-6904/8/2

Cite this

@article{19cb58ce9d75495b89d247b89bde1a39,

title = "Renal safety of zoledronic acid with thalidomide in patients with myeloma: a pharmacokinetic and safety sub-study",

author = "Andrew Spencer and Andrew Roberts and Nola Kennedy and Christina Ravera and Serge Cremers and Sanela Bilic and Teresa Neeman and Michael Copeman and Horst Schran and Kevin Lynch",

year = "2007",

doi = "1472-6904/8/2",

language = "English",

volume = "8",

pages = "1--4",

journal = "Pharmacology and Toxicology",

publisher = "Blackwell Publishing Ltd",

number = "2",

}

TY - JOUR

T1 - Renal safety of zoledronic acid with thalidomide in patients with myeloma: a pharmacokinetic and safety sub-study

AU - Spencer, Andrew

AU - Roberts, Andrew

AU - Kennedy, Nola

AU - Ravera, Christina

AU - Cremers, Serge

AU - Bilic, Sanela

AU - Neeman, Teresa

AU - Copeman, Michael

AU - Schran, Horst

AU - Lynch, Kevin

PY - 2007

Y1 - 2007

U2 - 1472-6904/8/2

DO - 1472-6904/8/2

M3 - Article

VL - 8

SP - 1

EP - 4

JO - Pharmacology and Toxicology

JF - Pharmacology and Toxicology

IS - 2

ER -